BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 25401497)

  • 1. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contrasting effect of macromolecular crowding on amyloid fibril formation.
    Ma Q; Fan JB; Zhou Z; Zhou BR; Meng SR; Hu JY; Chen J; Liang Y
    PLoS One; 2012; 7(4):e36288. PubMed ID: 22558423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibril formation of the rabbit/human/bovine prion proteins.
    Zhou Z; Yan X; Pan K; Chen J; Xie ZS; Xiao GF; Yang FQ; Liang Y
    Biophys J; 2011 Sep; 101(6):1483-92. PubMed ID: 21943430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
    Walsh P; Yau J; Simonetti K; Sharpe S
    Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
    Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
    Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-induced modulation of the pathway of amyloid fibril formation by the mouse prion protein.
    Jain S; Udgaonkar JB
    Biochemistry; 2010 Sep; 49(35):7615-24. PubMed ID: 20712298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for conversion of prion protein into amyloid fibrils.
    Breydo L; Makarava N; Baskakov IV
    Methods Mol Biol; 2008; 459():105-15. PubMed ID: 18576151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of amyloid fibrils from β-amylase.
    Luo JC; Wang SC; Jian WB; Chen CH; Tang JL; Lee CI
    FEBS Lett; 2012 Mar; 586(6):680-5. PubMed ID: 22449963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of amyloid fibrils formed by the prion protein derived peptides PrP(244-249) and PrP(245-250).
    Yau J; Sharpe S
    J Struct Biol; 2012 Nov; 180(2):290-302. PubMed ID: 22929126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.
    Ostapchenko VG; Makarava N; Savtchenko R; Baskakov IV
    J Mol Biol; 2008 Nov; 383(5):1210-24. PubMed ID: 18789949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.